Enhanced vitamin K expenditure as a major contributor to vitamin K deficiency in COVID-19

Int J Infect Dis. 2022 Dec:125:275-277. doi: 10.1016/j.ijid.2022.10.030. Epub 2022 Oct 28.

Abstract

Objectives: Vitamin K deficiency consistently associates with worse clinical outcome in COVID-19 patients. However, whether this is due to increased expenditure during inflammation or poor vitamin K status prior to infection remained unknown.

Methods: Dp-ucMGP levels of 128 individuals were measured for the post-MONICA study and were compared to SARS-CoV-2 PCR testing results.

Results: Dp-ucMGP levels prior to COVID-19 infection were not significantly different comparing PCR-negative, PCR-positive and not hospitalized, and PCR-positive and hospitalized patients.

Conclusion: In this study, we demonstrate normal vitamin K status prior to infection in SARS-CoV-2 positive patients, supporting the theory of increased utilisation during disease.

Keywords: COVID-19; Dp-ucMGP; Elastic fibers; Matrix Gla Protein; Vitamin K.

MeSH terms

  • Biomarkers
  • COVID-19*
  • Calcium-Binding Proteins
  • Extracellular Matrix Proteins
  • Health Expenditures
  • Humans
  • SARS-CoV-2
  • Vitamin K
  • Vitamin K Deficiency* / complications

Substances

  • Vitamin K
  • Extracellular Matrix Proteins
  • Calcium-Binding Proteins
  • Biomarkers